URGNInvestor Events•globenewswire•
UroGen Pharma to Present at Upcoming Investor Conferences
Sentiment:Negative (30)
Summary
PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in September.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 21, 2025 by globenewswire